Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel radiotracer shows potential for PET imaging of LPA-1 receptor expression

July 4, 2014

Oncoceutics presents preclinical data on lead compound

July 3, 2014

FOXO1 as a potential therapeutic target for diabetes demonstrated with AS-1842856

July 3, 2014

Osteogenesis improved in patients with hypophosphatasia

July 3, 2014

Pharmacodynamic effects of AZD-3241 revealed in PD patients

July 3, 2014

ISIS-GCGRRx improves glycemic control in type 2 diabetes trial

July 2, 2014

Imaging neuroinflammation with a novel PET tracer

July 2, 2014

Clinical trial of cancer vaccine ETBX-011 completed

July 2, 2014

Phase I data reported for REGN-1400 in patients with cancer

July 2, 2014

Novel chimeric fusion protein reduces arthritis in a mouse model

July 1, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...